Discontinuing long-term GH replacement therapy - A randomized, placebo-controlled crossover trial in adult GH deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 9, 2012, Pages 3185-3195

  Nyström, Helena Filipsson ^a,b   Barbosa, Edna J L ^a,b   Nilsson, Anna G ^a,b   Norrman, Lise Lott ^a,b   Ragnarsson, Oskar ^a,b   Johannsson, Gudmundur ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN GROWTH HORMONE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; ADULT GROWTH HORMONE DEFICIENCY; AGED; ANTHROPOMETRY; ARTHRALGIA; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CHOLECYSTECTOMY; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; EMOTIONAL BEHAVIOR; EMOTIONALITY; EXTRACELLULAR FLUID; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HEART ATRIUM FIBRILLATION; HIP CIRCUMFERENCE; HIP PAIN; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTRAABDOMINAL FAT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METABOLISM; MUSCLE STRENGTH; MYALGIA; NOTTINGHAM HEALTH PROFILE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGICAL DETERIORATION; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOCIAL ISOLATION; SUBCUTANEOUS FAT; THIGH MUSCLE AREA; TIBIA FRACTURE; TREATMENT WITHDRAWAL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; ANTHROPOMETRY; BLOOD PRESSURE; BODY COMPOSITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTRIC IMPEDANCE; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MOTOR ACTIVITY; MUSCLE STRENGTH; MUSCLE, SKELETAL; PITUITARY DISEASES; QUALITY OF LIFE; RECOMBINANT PROTEINS; SUBSTANCE WITHDRAWAL SYNDROME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84866166154     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2006     Document Type: Article

References (37)

1. Stochholm K, Christiansen J, Laursen T, Gravholt CH 2007 Mortality and reduced growth hormone secretion. Horm Res 68(Suppl 5):173-176
2. Svensson J, Bengtsson BA, Rosén T, Odén A, Johannsson G 2004 Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. J Clin Endocrinol Metab 89:3306-3312 (Pubitemid 38960692)
3. Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P 2004 Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab 89:2192-2199 (Pubitemid 38619852)
4. Burman P, Broman JE, Hetta J, Wiklund I, Erfurth EM, Hagg E, Karlsson FA 1995 Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GHin a placebo-controlled 21-month trial. J Clin Endocrinol Metab 80:3585-3590
5. Arwert LI, Veltman DJ, Deijen JB, van Dam PS, Drent ML 2006 Effects of growth hormone substitution therapy on cognitive functioning in growth hormone deficient patients: a functional MRI study. Neuroendocrinology 83:12-19 (Pubitemid 43877917)
6. Baum HB, Katznelson L, Sherman JC, Biller BM, Hayden DL, Schoenfeld DA, Cannistraro KE, Klibanski A 1998 Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J Clin Endocrinol Metab 83:3184-3189 (Pubitemid 28500954)
7. Florkowski CM, Stevens I, Joyce P, Espiner EA, Donald RA 1998 Growth hormone replacement does not improve psychological wellbeing in adult hypopituitarism: a randomized crossover trial. Psychoneuroendocrinology 23:57-63 (Pubitemid 28252967)
8. Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR 1992 Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf) 36:45-52
9. Woodhouse LJ, Mukherjee A, Shalet SM, Ezzat S 2006 The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr Rev 27:287-317
10. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Smethurst LE, Shalet SM 1999 Influences on quality of life in GH deficient adults and their effect on response to treatment. Clin Endocrinol (Oxf) 51:565-573
11. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R 2005 Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366:1267-1278
12. Koltowska-Häggström M, Mattsson AF, Monson JP, Kind P, Badia X, Casanueva FF, Busschbach J, Koppeschaar HP, Johannsson G 2006 Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life? Eur J Endocrinol 155:109-119 (Pubitemid 44109071)
13. Götherström G, Bengtsson BA, Bosaeus I, Johannsson G, Svensson J 2007 A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. J Clin Endocrinol Metab 92:1442-1445 (Pubitemid 46562361)
14. Mauras N, Pescovitz OH, Allada V, Messig M, Wajnrajch MP, Lippe B 2005 Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial. J Clin Endocrinol Metab 90:3946-3955 (Pubitemid 41065023)
15. Wirén L, Johannsson G, Bengtsson BA 2001 A prospective investigation of quality of life and psychological well-being after the discontinuation of GH treatment in adolescent patients who had GH deficiency during childhood. J Clin Endocrinol Metab 86:3494-3498 (Pubitemid 32761683)
16. Stouthart PJ, Deijen JB, Roffel M, Delemarre-van de Waal HA 2003 Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy. Psychoneuroendocrinology 28:612-626 (Pubitemid 36522728)
17. Johannsson G, Albertsson-Wikland K, Bengtsson BA 1999 Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children. J Clin Endocrinol Metab 84:4516-4524
18. McMillan CV, Bradley C, Gibney J, Healy ML, Russell-Jones DL, Sönksen PH 2003 Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency. Clin Endocrinol (Oxf) 59:467-475 (Pubitemid 37188177)
19. McMillan CV, Bradley C, Gibney J, Russell-Jones DL, Sönksen PH 2003 Evaluation of two health status measures in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 58:436-445 (Pubitemid 36390615)
20. Biller BM, Sesmilo G, Baum HB, Hayden D, Schoenfeld D, Klibanski A 2000 Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency. J Clin Endocrinol Metab 85:970-976 (Pubitemid 32269335)
21. McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L, Wíren L 1999 The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res 8:373-383 (Pubitemid 29369642)
22. Hunt SM, McEwen J 1980 The development of a subjective health indicator. Sociol Health Illn 2:231-246 (Pubitemid 11123591)
23. Dupuy H 1984 The psychological general well-being (PGWB) index. New York: Le Jacq Publishing Inc.
24. Franco C, Brandberg J, Lönn L, Andersson B, Bengtsson BA, Johannsson G 2005 Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. J Clin Endocrinol Metab 90:1466-1474 (Pubitemid 40464006)
25. Chowdhury B, Sjöström L, Alpsten M, Kostanty J, Kvist H, Löfgren R 1994 A multicompartment body composition technique based on computerized tomography. Int J Obes Relat Metab Disord 18:219-234 (Pubitemid 24123457)
26. Mazess RB, Barden HS, Bisek JP, Hanson J 1990 Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and softtissue composition. Am J Clin Nutr 51:1106-1112
27. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
28. Gelding SV, Robinson S, Lowe S, Niththyananthan R, Johnston DG 1994 Validation of the low dose short insulin tolerance test for evaluation of insulin sensitivity. Clin Endocrinol (Oxf) 40:611-615 (Pubitemid 24194664)
29. Baecke JA, Burema J, Frijters JE 1982 A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936-942 (Pubitemid 13214364)
30. Götherström G, Bengtsson BA, Sunnerhagen KS, Johannsson G, Svensson J 2005 The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients. Clin Endocrinol (Oxf) 62:105-113 (Pubitemid 40178774)
31. Wirén L, Bengtsson BA, Johannsson G 1998 Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency. Clin Endocrinol (Oxf) 48:613-620 (Pubitemid 28252998)
32. Sesmilo G, Miller KK, Hayden D, Klibanski A 2001 Inflammatory cardiovascular risk markers in women with hypopituitarism. J Clin Endocrinol Metab 86:5774-5781 (Pubitemid 33152623)
33. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sönksen PH, Tanaka T, Thorne M 1998 Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83:382-395 (Pubitemid 28496511)
34. Fors H, Bjarnason R, Wirént L, Albertsson-Wikland K, Bosaeust L, Bengtsson BA, Johannsson G 2001 Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents. Clin Endocrinol (Oxf) 55:617-624 (Pubitemid 34207706)
35. Krusenstjerna-Hafstrøm T, Clasen BF, Møller N, Jessen N, Pedersen SB, Christiansen JS, Jørgensen JO 2011 Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults. J Clin Endocrinol Metab 96:2548-2557
36. Sjöholm A, Nyström T 2005 Endothelial inflammation in insulin resistance. Lancet 365:610-612 (Pubitemid 40247919)
37. de Koning L, Merchant AT, Pogue J, Anand SS 2007 Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 28:850-856 (Pubitemid 47343598)